Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370446 · ClinicalTrials.gov registry record
Testing a Personalize Medication Log for Patients With Lymphoma
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 5
- Enrollment target
NCT02370446: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02370446 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02370446 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional information is helpful and if having this additional information about their treatment schedule has an effect on their quality of life.
Primary Outcome
as identified qualitatively through the process of cognitive interviewing and further measured with the satisfaction question on the Patient Satisfaction and Treatment Data Sheet
Interventions
- BEHAVIORAL questionnaires
- OTHER standard of care
- BEHAVIORAL Cognitive Interview
- OTHER personalized medication log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-01 |
What the finished NCT02370446 record still lists
NCT02370446 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which questionnaires is the first listed.
NCT02370446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02370446 about?
NCT02370446 is a clinical study titled "Testing a Personalize Medication Log for Patients With Lymphoma". The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional ...
What is the current status of trial NCT02370446?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02370446?
The interventions under investigation include: questionnaires (BEHAVIORAL), standard of care (OTHER), Cognitive Interview (BEHAVIORAL), personalized medication log (OTHER).
Who is sponsoring clinical trial NCT02370446?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia